(Q35078721)

6 August 2017

1 reference

title

Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides (English)

1 reference

6 August 2017

1

Thierry Soussi

1 reference

6 August 2017

Christophe Béroud

2

0 references

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

21

1 reference

6 August 2017

192-200

1 reference

6 August 2017

3

1 reference

TP53 family members and human cancers

6 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

The UMD-p53 database: new mutations and analysis tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

TP53 tumor suppressor gene: a model for investigating human mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Time for a unified system of mutation description and reporting: a review of locus-specific mutation databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Cytosine methylation determines hot spots of DNA damage in the human P53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Mutations of the RET proto-oncogene in Hirschsprung's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Splice mutations in the p53 gene: case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

The p53 and Mdm2 families in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Disrupting TP53 in mouse models of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Assessing TP53 status in human tumours to evaluate clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Alleles of the APC gene: an attenuated form of familial polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

p53, proto-oncogene and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Characterization of germline TP53 splicing mutations and their genetic and functional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Clinical implications of p53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Regional analysis of p53 mutations in rheumatoid arthritis synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Involvement of 5-methylcytosine in sunlight-induced mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Positional cloning moves from perditional to traditional

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Mutation detection 2001: Novel technologies, developments and applications for analysis of the human genome. Proceedings of the 6th International Symposium on Mutations in the Human Genome. Bled, Slovenia, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

VARIATION, DATABASES, and DISEASE: new directions for human mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Focus on the p53 gene and cancer: advances in TP53 mutation research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

inferred from DOI database lookup

7 January 2021

based on heuristic

Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10189

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HUMU.10189

1 reference

6 August 2017

1 reference

PubMed ID

12619105